Hyderabad-based Bharat Biotech has submitted data from Phase 3 clinical trials of BBV154, its intranasal Covid vaccine candidate, to the drug regulator.
Senior scientist Nallathamby Kalaiselvi has been appointed as the Director General of the Council of Scientific and Industrial Research (CSIR), for two years.
EXAMIANS